ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Medicure Inc

Medicure Inc (MPH)

0,89
0,00
(0,00%)
Geschlossen 24 Dezember 10:00PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,89
Gebot
0,88
Fragen
0,99
Volumen
2.000
0,89 Tagesbereich 0,89
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
0,89
Handelsbeginn
0,89
Letzte Trade
2000
@
0.89
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
10.436.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-10,08
Gewinn pro Aktie (EPS)
-0,09
Erlöse
21,69M
Nettogewinn
-922k

Über Medicure Inc

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Winnipeg, Manitoba, Can
Gegründet
-
Medicure Inc is listed in the Biological Pds,ex Diagnstics sector of the TSX Venture Börse with ticker MPH. The last closing price for Medicure was $0,89. Over the last year, Medicure shares have traded in a share price range of $ 0,00 to $ 0,00.

Medicure currently has 10.436.000 shares in issue. The market capitalisation of Medicure is $9,29 million. Medicure has a price to earnings ratio (PE ratio) of -10.08.

MPH Neueste Nachrichten

Medicure reiterates its commitment to providing exceptional access to its branded pitavastatin (zypitamag) to people living with hiv

    MEDICURE REITERATES ITS COMMITMENT TO PROVIDING EXCEPTIONAL ACCESS TO ITS BRANDED PITAVASTATIN (ZYPITAMAG) TO PEOPLE LIVING WITH HIV   WINNIPEG, CANADA –...

Algernon Pharmaceuticals Announces New Chief Financial Officer

VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage...

Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian Cancer

LONDON and REDWOOD CITY, Calif. and HOUSTON, Texas, April 30, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical...

Mereo BioPharma to Present at the 20th Annual Needham Virtual Healthcare Conference

LONDON and REDWOOD City, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on...

Mereo BioPharma Reports Full Year 2020 Financial Results and Recent Highlights

-- Ultragenyx Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta Further Strengthened Management Team OncXerna Global Licensing Agreement for Navicixizumab...

Mereo BioPharma to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference

LONDON and REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on...

Mereo BioPharma Group plc Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriter...

LONDON and REDWOOD CITY, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on...

Mereo BioPharma Group plc Announces Pricing of Public Offering of American Depositary Shares

LONDON and REDWOOD CITY, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on...

Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares

LONDON and REDWOOD CITY, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on...

Ultragenyx and Mereo BioPharma Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta

Clinical-stage monoclonal antibody in development for rare genetic bone disease that builds on Ultragenyx’s existing bone franchise Ultragenyx leads and funds development to approval; Mereo...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

MPH - Frequently Asked Questions (FAQ)

What is the current Medicure share price?
The current share price of Medicure is $ 0,89
How many Medicure shares are in issue?
Medicure has 10.436.000 shares in issue
What is the market cap of Medicure?
The market capitalisation of Medicure is CAD 9,29M
What is the 1 year trading range for Medicure share price?
Medicure has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Medicure?
The price to earnings ratio of Medicure is -10,08
What is the cash to sales ratio of Medicure?
The cash to sales ratio of Medicure is 0,43
What is the reporting currency for Medicure?
Medicure reports financial results in CAD
What is the latest annual turnover for Medicure?
The latest annual turnover of Medicure is CAD 21,69M
What is the latest annual profit for Medicure?
The latest annual profit of Medicure is CAD -922k
What is the registered address of Medicure?
The registered address for Medicure is 2-1250 WAVERLEY STREET, WINNIPEG, MANITOBA, R3T 6C6
What is the Medicure website address?
The website address for Medicure is www.medicure.com
Which industry sector does Medicure operate in?
Medicure operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ACAP.PAtlas One Capital Corporation
$ 0,03
(100,00%)
10,1k
TVITVI Pacific Inc
$ 0,01
(100,00%)
4k
ETUE2gold Inc
$ 0,01
(100,00%)
22,5k
NKW.HOceanic Wind Energy Inc
$ 0,055
(57,14%)
98,1k
VRYPetro Victory Energy Corp
$ 1,50
(51,52%)
1,02k
PPMPacific Imperial Mines Inc
$ 0,005
(-66,67%)
4,67M
PTP.HPetrichor Energy Inc
$ 0,005
(-50,00%)
1.000
MAHMarksmen Energy Inc
$ 0,005
(-50,00%)
440,02k
ADEAdex Mining Inc
$ 0,005
(-50,00%)
90k
FV.HFirestone Ventures Inc
$ 0,05
(-37,50%)
4k
SSESilver Spruce Resources Inc
$ 0,005
(0,00%)
8,84M
AUUAALUULA Composites Inc
$ 0,045
(-10,00%)
8,73M
QNCQuantum Emotion Corp
$ 0,53
(21,84%)
6,77M
GPUSAlset AI Ventures Inc
$ 0,11
(15,79%)
4,74M
PPMPacific Imperial Mines Inc
$ 0,005
(-66,67%)
4,67M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen